Absorption, distribution, metabolism, and excretion of [<sup>14</sup>C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats.
- DOI
- 10.1007/s00280-022-04485-5
- Published
- 2022-10-25
- Container
- Cancer Chemother Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-022-04485-5,
title = {Absorption, distribution, metabolism, and excretion of [<sup>14</sup>C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats.},
author = {Li XM and Zheng YD and Zhang YF and Huan XJ and Yang C and Liu ML and Shen XK and Yang CH and Diao XX.},
year = {2022},
journal = {Cancer Chemother Pharmacol},
doi = {10.1007/s00280-022-04485-5},
url = {https://doi.org/10.1007/s00280-022-04485-5}
}RIS
TY - JOUR TI - Absorption, distribution, metabolism, and excretion of [<sup>14</sup>C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats. AU - Li XM AU - Zheng YD AU - Zhang YF AU - Huan XJ AU - Yang C AU - Liu ML AU - Shen XK AU - Yang CH AU - Diao XX. PY - 2022 JO - Cancer Chemother Pharmacol DO - 10.1007/s00280-022-04485-5 UR - https://doi.org/10.1007/s00280-022-04485-5 ER -
APA
XM, L., YD, Z., YF, Z., XJ, H., C, Y., ML, L., XK, S., CH, Y., & XX., D. (2022). Absorption, distribution, metabolism, and excretion of [<sup>14</sup>C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats.. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-022-04485-5
Source records
- europe-pmc · retrieved 2026-09-27T00:17:16.767Z